| Product Name | MF | CAS | Details |
|---|
| 2-(2-Fluorophenoxy)-N'-hydroxyethanimidamide | C8H9FN2O2 | 1016817-25-6 | Details |
| 1-(4-Methylbenzenesulfonyl)propan-2-ol | C10H14O3S | 85870-05-9 | Details |
| 1-(4-Fluorobenzoyl)cyclopropan-1-amine hydrochloride | C10H11ClFNO | 1803592-60-0 | Details |
| 4-Methoxyphenyl β-D-glucopyranoside | C13H18O7 | 6032-32-2 | Details |
| (S)-3-Boc-5-methyl-1,2,3-oxathiazolidine-2,2-dioxide ee | C8H15NO5S | 396074-50-3 | Details |
| 1-(5-Acetyl-2,4-dimethoxyphenyl)ethan-1-one | C12H14O4 | 3098-67-7 | Details |
| HBG1 protein (His tag) | Details |
| LY 309887 | C19H23N5O6S | 127228-54-0 | Details |
| N,N-Diethylpyrrolidine-2-carboxamide hydrochloride | C9H19ClN2O | 1048649-03-1 | Details |
| KN 93 | C26H29ClN2O4S | 139298-40-1 | Details |
| 2-Phenyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine | C16H19BN2O2 | 1319255-85-0 | Details |
| Acetylvirolin | C23H28O6 | 916264-22-7 | Details |
| 1,4-Dioxane-2,5-dimethanol | C6H12O4 | 14236-12-5 | Details |
| 2-Ethoxy-1-naphthaldehyde | C13H12O2 | 19523-57-0 | Details |
| Glycine sodium salt hydrate | C2H4NNaO2.xH2O | 207300-76-3 | Details |
| 2,6-Diethyl-4-thioisonicotinamide | C10H14N2S | 1391052-80-4 | Details |
| 4,4'-Dihydroxydiphenylmethane | C13H12O2 | 620-92-8 | Details |
| Fmoc-Pro-Phe-OH | C29H28N2O5 | 120943-07-9 | Details |
| 2-Carboxymethyl-benzoic acid tert-butyl ester | C13H16O4 | 168072-81-9 | Details |
| 1,11-Bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzyl)-1,4,8,11-tetraazacyclotetradecane | C46H84N12 | 771464-86-9 | Details |
| 2-furyl 4-((2,4,5-trichlorophenyl)sulfonyl)piperazinyl ketone | C15H13Cl3N2O4S | 669749-42-2 | Details |
| 2-Bromo-4-(cyclopentyloxy)-5-methoxybenzaldehyde | C13H15BrO3 | 692281-23-5 | Details |
| 1-[(4-Fluorophenyl)methyl]-3-methylpiperazine dihydrochloride | C12H18ClFN2 | 1461714-19-1 | Details |
| 4-Chloro-3-pyridinesulfonamide | C5H5ClN2O2S | 33263-43-3 | Details |
| ATG4A antibody | Details |
| Lys-conopressin-G | Details |
| Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro-Ala) | C25H40N10O10 | 128857-77-2 | Details |
| 2-Methyl-D-cysteine hydrochloride | C4H10ClNO2S | 151062-55-4 | Details |
| Potassium trifluoro[3-(morpholin-4-yl)prop-1-en-2-yl]boranuide | C7H12BF3KNO | 1357559-50-2 | Details |
| 4-Chloro-6,7-diethoxyquinoline | C13H14ClNO2 | 767225-24-1 | Details |
| Picrotin | C15H18O7 | 21416-53-5 | Details |
| 1-Methoxy-4-methyl-1H-imidazole-5-carboxylic acid hydrochloride | 2375269-15-9 | Details |
| 3-{[(2-Ethoxyethyl)amino]methyl}phenol | C11H17NO2 | 1154558-79-8 | Details |
| 5-(5'-Chloro-2'-hydroxy-4'-methylphenyl)-isoxazole | C10H8ClNO2 | 213690-32-5 | Details |
| rac 5-Keto Fluvastatin | C24H24FNO4 | 1160169-39-0 | Details |
| Ethyl 4-methoxy-3-oxobutanoate | C7H12O4 | 66762-68-3 | Details |
| Ceresin | C30H50O2 | 8001-75-0 | Details |
| HXB2 gag NO-69 | C75H126N22O23S | Details |
| DKC1 antibody | Details |
| AKT1S1 antibody | Details |
| 2-((2,3-dimethyl-5-oxo-1-phenyl(3-pyrazolin-4-yl))amino)-2-(1,3-dioxoindan-2-ylidene)ethanenitrile | C22H16N4O3 | 38756-20-6 | Details |
| 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine | C15H22FN3O6 | 910129-15-6 | Details |
| 5-Chloro-[1,6]naphthyridine | C8H5ClN2 | 23616-32-2 | Details |
| Fmoc-NH-PEG8-CH2CH2COOH | C34H49NO12 | 756526-02-0 | Details |
| O,o-Dimethyl dithiophosphate-13C2 ammonium | C2H10NO2PS2 | 1329610-82-3 | Details |
| 3-(2,3-Dihydro-1-benzofuran-5-yl)aniline | C14H13NO | 893637-27-9 | Details |
| 2-Cyclohexylazepane hydrochloride | C12H24ClN | 1315367-47-5 | Details |
| 6-Bromo-5-fluoro-1,3-benzothiazol-2-amine | C7H4BrFN2S | 1022151-32-1 | Details |
| 3-Bromo-1-methylpyrrolidin-2-one | C5H8BrNO | 33693-57-1 | Details |
| Encainide | C22H28N2O2 | 66778-36-7 | Details |
| 2-(1-Phenyl-ethylamino)-ethanol | C10H15NO | 6623-43-4 | Details |
| Wnt/β-catenin agonist 1 | C22H25N3O2 | 2305372-67-0 | Details |
| 1-Methyl-4-(methylcarbamoyl)-1H-pyrazole-5-carboxylic acid | C7H9N3O3 | 1006478-07-4 | Details |
| Sodium 2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-3-sulfonate | C10H12NNaO4S | 1803589-49-2 | Details |
| rac-(1R,3S,5S)-5-Hydroxycyclohexane-1,3-dicarboxylic acid | C8H12O5 | 38859-10-8 | Details |
| Sodium dimethyldithiocarbamate hydrate | C3H10NNaOS2 | 207233-95-2 | Details |
| 2-[(1S)-1-[(6-Amino-5-cyanopyrimidin-4-yl)amino]ethyl]-4-oxo-3-phenylpyrrolo[2,1-F][1,2,4]triazine-5-carbonitrile | C20H15N9O | 1403947-26-1 | Details |
| 5-Methyl-1-(2-methylphenyl)-1H-pyrazole-3-carboxylic acid | C12H12N2O2 | 1020724-19-9 | Details |
| 2-(4-Bromophenyl)-2-methyloxetane | C10H11BrO | 1102376-56-6 | Details |
| 3,3-Difluoro-1-methylcyclobutanecarboxylic acid | C6H8F2O2 | 227607-43-4 | Details |
| 9-Ethyladenine | C7H9N5 | 2715-68-6 | Details |
| 1-Bromo-3-(4-methoxyphenyl)propan-2-one | C10H11BrO2 | 20772-13-8 | Details |
| 5-(Diethoxymethyl)-3-ethyl-1,2,4-oxadiazole | C9H16N2O3 | 1339595-31-1 | Details |
| 4-Bromo-N-[(1-methyl-1H-pyrazol-4-yl)methyl]aniline | C11H12BrN3 | 1152858-05-3 | Details |
| FAM50A antibody | Details |
| H-MN-OH | Details |
| Coronavirus (SARS-CoV-2) Spike NTD - Purified from HEK293 | Details |
| 1-(5-Methyl-1,3-oxazol-2-yl)ethan-1-amine | C6H10N2O | 1017179-33-7 | Details |
| MAGE-A3 (195-203) | C45H82N10O10S | Details |
| RNF170 Blocking Peptide | Details |
| (1,2,3,4-Tetrahydronaphthalen-1-yl)urea | C11H14N2O | 58490-97-4 | Details |
| 1-(2,2,2-Trifluoroethyl)piperidin-3-one | C7H10F3NO | 1517389-96-6 | Details |
| 4-(1-Carbamoyl-1-methylethyl)benzene-1-sulfonyl chloride | C10H12ClNO3S | 1342111-86-7 | Details |
| TLK1 Blocking Peptide | Details |
| 17a OH Progesterone antibody | Details |
| GRPEL1 Blocking Peptide | Details |
| 2-Benzyl 1-tert-butyl pyrrolidine-1,2-dicarboxylate | C17H23NO4 | 2089093-10-5 | Details |
| SR11237 | C24H28O4 | 146670-40-8 | Details |
| SLFNL1 antibody | Details |
| 1,2,3,4-Tetrahydroisoquinoline-5-sulfonamide | C9H12N2O2S | 1153247-92-7 | Details |
| 2,6-Dimethylpiperidine-1-carbonyl chloride | C8H14ClNO | 54486-12-3 | Details |
| 3-[(2-Methylphenyl)formamido]-3-(3-phenoxyphenyl)propanoic acid | 2155856-17-8 | Details |
| 5-(4-Methyl-1,3-thiazol-5-yl)-1,3-oxazole | C7H6N2OS | 1461708-29-1 | Details |
| H-AK^FVAAWTLK^AAA-OH | Details |
| 6-(1,5-Dimethyl-1H-pyrazol-4-yl)-3-methyl-1-propyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | C16H19N5O2 | 1004727-50-7 | Details |
| 1-(Pyridin-2-yl)hexan-2-ol | C11H17NO | 91339-85-4 | Details |
| rac-(1R,2R)-2-(4-Methylphenyl)cyclopropane-1-carbohydrazide hydrochloride | 2173998-98-4 | Details |
| SV2A Blocking Peptide | Details |
| 3-(Difluoromethoxy)cyclohexan-1-amine | C7H13F2NO | 1603104-35-3 | Details |
| 4-(Propan-2-yloxy)-2-(trifluoromethyl)benzonitrile | C11H10F3NO | 1094436-68-6 | Details |
| 3-Bromofuran-2-carbonitrile | C5 H2 Br N O | 32460-11-0 | Details |
| Ferritin Light Chain, Recombinant | Details |
| 1-(2-Fluoro-6-methoxyphenyl)ethan-1-amine | C9H12FNO | 1019602-82-4 | Details |
| 3-Methylimidazo[1,2-a]pyridine-8-carboxylic acid hydrochloride | 2375271-46-6 | Details |
| ECHDC1 Blocking Peptide | Details |
| 4-Cyano-N-(3-ethynylphenyl)benzene-1-sulfonamide | C15H10N2O2S | 208943-22-0 | Details |
| 1-Methyl-3-(trifluoromethyl)-1H-pyrazole-5-carbohydrazide | C6H7F3N4O | 1001518-78-0 | Details |
| 2-(1H-Pyrazol-4-yl)-1,3-thiazole | C6H5N3S | 1228558-14-2 | Details |
| MDR1 antibody (FITC) | Details |
| H-EVTVPVFYPTEK^-OH | Details |
| Product Total： Product Page： | ||||
| 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 | ||||